Veterinary Medicines

CALCIO-CALIER FORTE

Authorised
  • Magnesium hypophosphite hexahydrate
  • Magnesium chloride hexahydrate
  • Calcium gluconate
Download as PDF

Product identification

Medicine name:
КАЛЦИО-КАЛИЕР ФОРТЕ
CALCIO-CALIER FORTE
Active substance:
  • Magnesium hypophosphite hexahydrate
  • Magnesium chloride hexahydrate
  • Calcium gluconate
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Magnesium hypophosphite hexahydrate
    3.38
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    64.30
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    515.70
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
  • Intravenous use
    • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Asklep-Pharma OOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2266-08.05.2014
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."